Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy.
Gebrael G, Sayegh N, Hage Chehade C, Jo Y, Narang A, Chigarira B, Tripathi N, Srivastava A, Tandar C, Williams JF, Garg D, Ji R, Maughan BL, Swami U, Agarwal N.
Gebrael G, et al. Among authors: ji r.
Prostate Cancer Prostatic Dis. 2025 Jan 31. doi: 10.1038/s41391-025-00936-1. Online ahead of print.
Prostate Cancer Prostatic Dis. 2025.
PMID: 39885371